News Story: Full Text
Sponsored By
Orbus Therapeutics Inc Clinical Trial for Recurrent Anaplastic Astrocytomas
Please Click On The Above Banner For More Details
Braintumor Website

 

FDA to consider approval of Avastin for brain tumors - ACTION NEEDED!


Posted on: 03/16/2009

Hi
 The FDA is going to review Avastin for approval for recurrent glioblastoma multiforme.  I will be speaking to the committee, asking that they approve it. 
 I want to say that I am speaking for a large number of people.  To do that, I need your permission and your views on the topic, and while you are at it, a letter from you. I have a survey on my website asking for your approval and a quick and easy way to send a letter. (Edit it first to suit your situation!)

Just go to:
http://virtualtrials.com/fda

It is really quick.
Fill it out, then ask your entire family and all of your friends to fill it out. Pass it along to the other online groups.  Even though it is focused on recurrent glioblastoma multiforme, everyone is welcome to give their opinion on it!

 

The deadline is 3/19/2009

Thanks
Al Musella, DPM
President
Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

 


Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740